This PIN announces an open market consultation and provides information about a planned pre-commercial procurement (PCP) carried out by the HSMonitor project, addressing the rising incidence of hypertension and the need for more effective management by empowering patients and the healthcare professionals involved in their care. HSMonitor is looking to procure R&D services in the form of a solution that will provide innovative ICT-enabled monitoring to improve health status and optimise hypertension care. The procurement should address the procurers' unmet needs relating to different aspects (building blocks) of hypertension care: early detection and prevention, healthier lifestyle and nutrition, optimised drug therapy and improving treatment adherence, use of devices and remote monitoring, personalised decision support, interoperability and integration, quality and outcome reporting, patient-professional collaboration and coordination, training and education.

Extended TitlePre-commercial Procurement of Innovative ICT-enabled Monitoring to Improve Health Status and Optimise Hypertension Care
Extended Description

The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected operator will be awarded a framework agreement that covers three R&D phases. The 3 phases are: solution design, prototype development, original development and validation and testing of a limited volume of first products or services. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best value-for-money solutions will be offered a specific contract for the next phase.

The procurement is expected to start in January 2021 and end in March 2023.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions.

Note: the estimated total value listed in Section II.1.5) includes VAT.

This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 856698 — HSMonitor ( The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.

Publication Date2020-01-20
Procurement StatusFuture
TypeNot applicable
Contract TypeServices
Award CriteriaNot applicable
OrganisationTürkiye Cumhuriyeti Sağlık Bakanlığı
Attention OfOzan Beyhan
AddressÜniversiteler Mah. Dumlupınar Bul. 6001. Cad. No: 9 Bilkent Çankaya, Turkey
Postal Code06800
Phone+90 3124718350
Fax+90 3124718297
Class Code73100000
Class DescriptionResearch and experimental development services
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)